*Data updated daily at 18:00 EAT
Cairo-based startup Grinta, a fintech-enabled B2B tech platform digitizing the pharmaceutical supply chain, raised USD 8 Mn in seed funding co-led by Raed Ventures and Nclude. Other investors include Silicon Valley-based Endeavor Catalyst and 500 Global, bringing its total funding to date to USD 9.5 Mn. The funds will be invested to scale Grinta’s full-stack tech platform, expand its team and accelerate its growth across the Egyptian market.
Grinta is a managed marketplace that modernizes the pharmaceutical supply chain by empowering independent pharmacies. The end-to-end platform offers a seamless and easy-to-use experience, giving access to the full spectrum of traceable pharmaceutical and medical products from multiple vendors in addition to providing fulfillment, demand planning, and inventory financing. The company is working with all stakeholders across the value chain, manufacturers, distributors, wholesalers, and pharmacies, to build a data-driven, reliable, and efficient pharmaceutical supply chain.